Literature DB >> 11937520

Cutting edge: anti-inflammatory properties of low levels of IFN-gamma.

Liat Flaishon1, Ian Topilski, David Shoseyov, Rami Hershkoviz, Elizabeth Fireman, Yoram Levo, Sylvia Marmor, Idit Shachar.   

Abstract

Activation of naive T and B cells occurs only within the context of organized lymphoid tissue. Thus, the continuous recirculation of mature lymphocytes is crucial for the development of primary immune response to foreign Ags. We have previously shown that low levels of IFN-gamma inhibit homing of B cells to the secondary lymphoid organs. In this study, we demonstrate that similarly low doses of IFN-gamma down-regulate integrin-mediated adhesion and migration of naive T and Th2 cells, and have a profound effect on the in vivo homing of naive T cells to the lymph nodes. Moreover, we show that these low doses of IFN-gamma have anti-inflammatory effects in an in vivo asthma model. Thus, in contrast to the proinflammatory effects of IFN-gamma at relatively high concentrations, low dose IFN-gamma appears to exert global suppressory effects on T cell trafficking and may have clinical application as an anti-inflammatory agent.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11937520     DOI: 10.4049/jimmunol.168.8.3707

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

1.  Inhibition of Pim1 kinase activation attenuates allergen-induced airway hyperresponsiveness and inflammation.

Authors:  Yoo Seob Shin; Katsuyuki Takeda; Yoshiki Shiraishi; Yi Jia; Meiqin Wang; Leila Jackson; A Dale Wright; Laura Carter; John Robinson; Erik Hicken; Erwin W Gelfand
Journal:  Am J Respir Cell Mol Biol       Date:  2011-11-10       Impact factor: 6.914

2.  Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health.

Authors:  Sefina Arif; Timothy I Tree; Thomas P Astill; Jennifer M Tremble; Amanda J Bishop; Colin M Dayan; Bart O Roep; Mark Peakman
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

3.  PD-L1(hi) retinal pigment epithelium (RPE) cells elicited by inflammatory cytokines induce regulatory activity in uveitogenic T cells.

Authors:  Yan Ke; Deming Sun; Guomin Jiang; Henry J Kaplan; Hui Shao
Journal:  J Leukoc Biol       Date:  2010-08-25       Impact factor: 4.962

4.  Retinal Astrocytes respond to IL-17 differently than Retinal Pigment Epithelial cells.

Authors:  Yan Ke; Guomin Jiang; Deming Sun; Henry J Kaplan; Hui Shao
Journal:  J Leukoc Biol       Date:  2009-08-18       Impact factor: 4.962

Review 5.  T cell subsets and their signature cytokines in autoimmune and inflammatory diseases.

Authors:  Itay Raphael; Saisha Nalawade; Todd N Eagar; Thomas G Forsthuber
Journal:  Cytokine       Date:  2014-10-30       Impact factor: 3.861

6.  Alteration of Interferon Gamma (IFN-γ) in Human Plasma with Graded Physical Activity.

Authors:  Ambarish Vijayaraghava; Radhika K
Journal:  J Clin Diagn Res       Date:  2014-06-20

7.  Anti-inflammatory role of IL-17 in experimental autoimmune uveitis.

Authors:  Yan Ke; Ke Liu; Guo-Qiang Huang; Yan Cui; Henry J Kaplan; Hui Shao; Deming Sun
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

8.  Prevention of type I diabetes transfer by glutamic acid decarboxylase 65 peptide 206-220-specific T cells.

Authors:  Seon-Kyeong Kim; Kristin V Tarbell; Maija Sanna; Mary Vadeboncoeur; Tibor Warganich; Mark Lee; Mark Davis; Hugh O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-20       Impact factor: 11.205

9.  FcgammaRIIb inhibits allergic lung inflammation in a murine model of allergic asthma.

Authors:  Nilesh Dharajiya; Swapnil V Vaidya; Hiroki Murai; Victor Cardenas; Alexander Kurosky; Istvan Boldogh; Sanjiv A Sur
Journal:  PLoS One       Date:  2010-02-22       Impact factor: 3.240

10.  Subcutaneous insulin B:9-23/IFA immunisation induces Tregs that control late-stage prediabetes in NOD mice through IL-10 and IFNgamma.

Authors:  G Fousteri; A Dave; A Bot; T Juntti; S Omid; M von Herrath
Journal:  Diabetologia       Date:  2010-05-20       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.